Close

Analyst Ratings for Pacific Biosciences of California (PACB)

PACB Rating Summary

PACB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on PACB
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $19.00 (+260.5%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/21/2022 Cantor Fitzgerald
» Updated 4/4/2022
Ross Osborn New Coverage Overweight
(N/A)
23.00
(N/A)
10.39
(5.27)
-49.28% Details
1/6/2022 Piper Sandler
» Updated 8/22/2022
Dave Westenberg New Coverage Neutral
(N/A)
6.00
(7.50)
18.98
(5.27)
-72.23% Details
Like PACB Ratings? Also take a look at SGFY, HOOD, AZTA, NTDOY

PACB Ratings News